Jan 26

Real Stories of How the Ryan White Program Helps Folks With HIV

How has the Ryan White Program helped people living with HIV? Why not let some of the beneficiaries tell you in their own words. That’s exactly what they do in “Ryan White. Real Lives. Stories on the Real Impact of the Ryan White Care Act,” a campaign spearheaded by the HIV Prevention Justice Alliance (HIV PJA).   The campaign’s goal is to ...
Read More
Jan 26

HUD Announces $1.8 Billion for Homeless Programs

  To support the Obama administration’s goal to end homelessness, the Department of Housing and Urban Development (HUD) has awarded $1.8 billion in grants for nearly 8,400 local homeless housing and service programs across the nation, Puerto Rico, Guam, and the U.S. Virgin Islands. The Continuum of Care grants will provide critically needed housing and support services to individuals and families experiencing ...
Read More
Jan 21

The Deep South Is Being Hit Hard by HIV/AIDS

The Deep South has the highest death rate of newly diagnosed AIDS cases in the country, according to new research which analyzes the growing epidemic in the region and seeks to articulate its causes, which include social stigma, rural geography, and poverty. Researchers at the University of North Carolina, Duke University, and the Centers for Disease Control worked together to analyze ...
Read More
Jan 6

The Berlin patient, first and only person 'cured' of HIV, speaks out

Timothy Ray Brown, long known only as the "Berlin Patient" had HIV for 12 years before he became the first person in the world to be cured of the infection following a stem cell transplant in 2007. He recalls his many years of illness, a series of difficult decisions, and his long road to recovery in the first-person account, "I ...
Read More
Dec 1

Starting HIV Meds Within a Year of Infection Helps Restore CD4s

Beginning antiretroviral (ARV) treatment for HIV within a year of the estimated date of seroconversion (EDS) improves the likelihood of returning an individual’s CD4 count to a normal level, provided CD4s are higher than 500 upon starting meds, Reuters reports. Publishing their findings in JAMA Internal Medicine, researchers analyzed data regarding 1,119 people from the ongoing U.S. Military HIV Natural ...
Read More
Nov 14

Successful treatments are helping HIV-infected persons achieve similar longevity as those without HIV

New research from the Johns Hopkins Bloomberg School of Public Health suggests that HIV-infected adults are at a higher risk for developing heart attacks, kidney failure and cancer. But, contrary to what many had believed, the researchers say these illnesses are occurring at similar ages as adults who are not infected with HIV. The findings appeared online last month in the ...
Read More
Oct 29

Elton John AIDS Foundation Invests in MSM, LGBT Programs

The Elton John AIDS Foundation is donating funds to new HIV programs focused on the U.S. LGBT population as well as on men who have sex with men (MSM) in South Africa, according to an EJAF press release. Sir Elton John and his partner David Furnish—the EJAF founder and chairman, respectively—met with Secretary of State John Kerry to ...
Read More
Oct 22

Social Security Announces 1.7 Percent Benefit Increase for 2015

Monthly Social Security and Supplemental Security Income (SSI) benefits for nearly 64 million Americans will increase 1.7 percent in 2015, the Social Security Administration announced today. The 1.7 percent cost-of-living adjustment (COLA) will begin with benefits that more than 58 million Social Security beneficiaries receive in January 2015. Increased payments to more than 8 million SSI beneficiaries will begin on December ...
Read More
Oct 17

'Wonder drug' which can reduce HIV risk by 92% could be offered on the NHS

An HIV 'wonder drug' could be made available on the NHS, in what has been hailed as the most significant breakthrough against the virus in a generation. A landmark trial in England is to be sped up after interim analysis of the the drug Truvada found it to be 'highly protective against HIV'. Campaigners have urged the NHS to offer the medication ...
Read More
Oct 8

People With HIV and Kidney Problems Should Avoid Viread (Tenofovir

While antiretroviral (ARV) therapy is beneficial for HIV-positive people with reduced kidney function, they should not take Viread (tenofovir), according to updated guidelines from the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA). Published in Clinical Infectious Diseases, the guidelines take into account the findings of large studies published since their last update in 2005. ...
Read More


Subscribe to News